Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

OMID RABBANI

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1033296587
CMS profile
319444
Location
SIMI VALLEY, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$3,147.79

183 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $3,147.79 183

By paying entity

PY2023 · entire year · sorted by reported total

Page 4 of 4; records 151–183 of 183 matching records. This page contains 33 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

OMID RABBANI

NPI 1033296587 · CMS profile ID 319444

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

SIMI VALLEY, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 4 of 4; records 151–183 of 183 matching records. This page contains 33 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1033296587?year=2023&recipient=provider&page=4#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
OMID RABBANI, NPI 1033296587, CMS profile ID 319444. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–183 of 183 matching records. This page contains 33 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1033296587?year=2023&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). OMID RABBANI, NPI 1033296587, CMS profile ID 319444. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–183 of 183 matching records. This page contains 33 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1033296587?year=2023&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
OMID RABBANI, NPI 1033296587, CMS profile ID 319444, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 4; records 151–183 of 183 matching records. This page contains 33 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1033296587?year=2023&recipient=provider&page=4#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

183 matching records · $3,147.79 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 183 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 151–183 of 183.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Alexion Pharmaceuticals, Inc. $24.4003/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017062845 CMS
SK Life Science, Inc. $2.5103/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1054703169 CMS
ABBVIE INC. $18.0503/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998180063 CMS
SK Life Science, Inc. $32.4803/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1054703153 CMS
PFIZER INC. $7.5703/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049596087 CMS
IDORSIA PHARMACEUTICALS US INC $23.8403/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034197587 CMS
ABBVIE INC. $8.1502/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998180061 CMS
TG Therapeutics, Inc. $23.5802/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051498859 CMS
Amneal Pharmaceuticals LLC $10.9902/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053526693 CMS
MDD US Operations, LLC $20.2302/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052891513 CMS
ARGENX US, INC. $19.4302/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060398625 CMS
PFIZER INC. $24.3702/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049596999 CMS
Genentech USA, Inc. $19.0302/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040495607 CMS
CSL Behring $19.4702/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1042932601 CMS
Amneal Pharmaceuticals LLC $23.0602/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053526687 CMS
PFIZER INC. $8.3702/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049563623 CMS
Biogen, Inc. $23.1002/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012166451 CMS
ABBVIE INC. $8.2002/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998180059 CMS
Eisai Inc. $20.3902/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023326179 CMS
EMD Serono, Inc. $24.3702/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032432043 CMS
IMPEL PHARMACEUTICALS INC. $15.1302/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 989367945 CMS
ABBVIE INC. $7.5901/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998180057 CMS
ABBVIE INC. $33.5101/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998180055 CMS
ABBVIE INC. $9.1201/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998180053 CMS
MDD US Operations, LLC $22.7101/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052891505 CMS
ABBVIE INC. $6.2201/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998180051 CMS
GENZYME CORPORATION $22.7701/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050004823 CMS
SK Life Science, Inc. $27.7101/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1054703099 CMS
SK Life Science, Inc. $3.9801/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1054703107 CMS
ARGENX US, INC. $17.5701/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060398617 CMS
Catalyst Pharmaceuticals, Inc. $18.7801/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048230939 CMS
ABBVIE INC. $7.2001/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998180049 CMS
TG Therapeutics, Inc. $25.0001/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051498847 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,637.17 102
PY2020 $2,236.96 141
PY2021 $2,313.11 141
PY2022 $2,784.81 186
PY2023 $3,147.79 183
PY2024 $84.11 4
PY2025 $20.18 1

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2019 Principal investigator $38,358.20 18

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

18 records in PY2019

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Eisai Inc. $13,845.20 08/22/2019 Non-covered Recipient Entity
SOUTHERN CALIFORNIA RESEARCH LLC
A Long-Term Multicenter, Randomized, Double-Blind, Controlled, Parallel Group Study of the Safety and Efficacy of Lemborexant in Subjects With Insomnia Disorder No dispute reported 06/30/2026 702560759
Principal investigator 1 Eisai Inc. $1,467.00 01/08/2019 Non-covered Recipient Entity
SOUTHERN CALIFORNIA RESEARCH LLC
A Long-Term Multicenter, Randomized, Double-Blind, Controlled, Parallel Group Study of the Safety and Efficacy of Lemborexant in Subjects With Insomnia Disorder No dispute reported 06/30/2026 702560725
Principal investigator 1 Eisai Inc. $1,376.00 01/08/2019 Non-covered Recipient Entity
SOUTHERN CALIFORNIA RESEARCH LLC
A Long-Term Multicenter, Randomized, Double-Blind, Controlled, Parallel Group Study of the Safety and Efficacy of Lemborexant in Subjects With Insomnia Disorder No dispute reported 06/30/2026 702560727
Principal investigator 1 Eisai Inc. $1,376.00 01/08/2019 Non-covered Recipient Entity
SOUTHERN CALIFORNIA RESEARCH LLC
A Long-Term Multicenter, Randomized, Double-Blind, Controlled, Parallel Group Study of the Safety and Efficacy of Lemborexant in Subjects With Insomnia Disorder No dispute reported 06/30/2026 702560729
Principal investigator 1 Eisai Inc. $1,519.00 01/08/2019 Non-covered Recipient Entity
SOUTHERN CALIFORNIA RESEARCH LLC
A Long-Term Multicenter, Randomized, Double-Blind, Controlled, Parallel Group Study of the Safety and Efficacy of Lemborexant in Subjects With Insomnia Disorder No dispute reported 06/30/2026 702560731
Principal investigator 1 Eisai Inc. $1,015.00 01/08/2019 Non-covered Recipient Entity
SOUTHERN CALIFORNIA RESEARCH LLC
A Long-Term Multicenter, Randomized, Double-Blind, Controlled, Parallel Group Study of the Safety and Efficacy of Lemborexant in Subjects With Insomnia Disorder No dispute reported 06/30/2026 702560733
Principal investigator 1 Eisai Inc. $1,467.00 01/08/2019 Non-covered Recipient Entity
SOUTHERN CALIFORNIA RESEARCH LLC
A Long-Term Multicenter, Randomized, Double-Blind, Controlled, Parallel Group Study of the Safety and Efficacy of Lemborexant in Subjects With Insomnia Disorder No dispute reported 06/30/2026 702560735
Principal investigator 1 Eisai Inc. $1,015.00 01/08/2019 Non-covered Recipient Entity
SOUTHERN CALIFORNIA RESEARCH LLC
A Long-Term Multicenter, Randomized, Double-Blind, Controlled, Parallel Group Study of the Safety and Efficacy of Lemborexant in Subjects With Insomnia Disorder No dispute reported 06/30/2026 702560737
Principal investigator 1 Eisai Inc. $1,519.00 01/08/2019 Non-covered Recipient Entity
SOUTHERN CALIFORNIA RESEARCH LLC
A Long-Term Multicenter, Randomized, Double-Blind, Controlled, Parallel Group Study of the Safety and Efficacy of Lemborexant in Subjects With Insomnia Disorder No dispute reported 06/30/2026 702560739
Principal investigator 1 Eisai Inc. $1,519.00 01/08/2019 Non-covered Recipient Entity
SOUTHERN CALIFORNIA RESEARCH LLC
A Long-Term Multicenter, Randomized, Double-Blind, Controlled, Parallel Group Study of the Safety and Efficacy of Lemborexant in Subjects With Insomnia Disorder No dispute reported 06/30/2026 702560741
Principal investigator 1 Eisai Inc. $1,661.00 01/08/2019 Non-covered Recipient Entity
SOUTHERN CALIFORNIA RESEARCH LLC
A Long-Term Multicenter, Randomized, Double-Blind, Controlled, Parallel Group Study of the Safety and Efficacy of Lemborexant in Subjects With Insomnia Disorder No dispute reported 06/30/2026 702560743
Principal investigator 1 Eisai Inc. $1,376.00 01/08/2019 Non-covered Recipient Entity
SOUTHERN CALIFORNIA RESEARCH LLC
A Long-Term Multicenter, Randomized, Double-Blind, Controlled, Parallel Group Study of the Safety and Efficacy of Lemborexant in Subjects With Insomnia Disorder No dispute reported 06/30/2026 702560745
Principal investigator 1 Eisai Inc. $1,519.00 01/08/2019 Non-covered Recipient Entity
SOUTHERN CALIFORNIA RESEARCH LLC
A Long-Term Multicenter, Randomized, Double-Blind, Controlled, Parallel Group Study of the Safety and Efficacy of Lemborexant in Subjects With Insomnia Disorder No dispute reported 06/30/2026 702560747
Principal investigator 1 Eisai Inc. $1,661.00 01/08/2019 Non-covered Recipient Entity
SOUTHERN CALIFORNIA RESEARCH LLC
A Long-Term Multicenter, Randomized, Double-Blind, Controlled, Parallel Group Study of the Safety and Efficacy of Lemborexant in Subjects With Insomnia Disorder No dispute reported 06/30/2026 702560749
Principal investigator 1 Eisai Inc. $1,376.00 01/08/2019 Non-covered Recipient Entity
SOUTHERN CALIFORNIA RESEARCH LLC
A Long-Term Multicenter, Randomized, Double-Blind, Controlled, Parallel Group Study of the Safety and Efficacy of Lemborexant in Subjects With Insomnia Disorder No dispute reported 06/30/2026 702560751
Principal investigator 1 Eisai Inc. $1,519.00 01/08/2019 Non-covered Recipient Entity
SOUTHERN CALIFORNIA RESEARCH LLC
A Long-Term Multicenter, Randomized, Double-Blind, Controlled, Parallel Group Study of the Safety and Efficacy of Lemborexant in Subjects With Insomnia Disorder No dispute reported 06/30/2026 702560753
Principal investigator 1 Eisai Inc. $1,661.00 01/08/2019 Non-covered Recipient Entity
SOUTHERN CALIFORNIA RESEARCH LLC
A Long-Term Multicenter, Randomized, Double-Blind, Controlled, Parallel Group Study of the Safety and Efficacy of Lemborexant in Subjects With Insomnia Disorder No dispute reported 06/30/2026 702560755
Principal investigator 1 Eisai Inc. $1,467.00 01/08/2019 Non-covered Recipient Entity
SOUTHERN CALIFORNIA RESEARCH LLC
A Long-Term Multicenter, Randomized, Double-Blind, Controlled, Parallel Group Study of the Safety and Efficacy of Lemborexant in Subjects With Insomnia Disorder No dispute reported 06/30/2026 702560757